Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 10, 1999, Pages 1927-1936

  Su, Xuefeng ^a,b   Brower, Gregory ^a,b   Janicki, Joseph S ^a,b   Chen, Yiu Fai ^a,b   Oparil, Suzanne ^a,b   Dell'Italia, Louis J ^a,b  

^a University of Alabama at Birmingham   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Heart failure; Hypertrophy; Natriuretic peptides; Receptors

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRAIN NATRIURETIC PEPTIDE; HORMONE RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION;

EID: 0032881727     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1025     Document Type: Article

References (43)

1. Ackermann U, Irizawa TG, Milojevic S, Sonnenberg H. Cardiovascular effects of atrial extracts in anesthetized rats. Can J Physiol Pharmacol. 62:1984;819-826.
2. Adachi S, Ito H, Ohta Y, Tanaka M, Ishiyama S, Nagata M, Toyozaki T, Hirata Y, Marumo F, Hiroe M. Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding. Am J Physiol. 268:1995;H162-H169.
3. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T. Clearance function of type C receptors of atrial natriuretic factor in rat. Am J Physiol. 256:1989;R469-R475.
4. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70:1990;665-699.
5. Brown LA, Nunez DJ, Wilkins MR. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest. 92:1993;2702-2712.
6. Brown LA, Nunez DJ, Brookes CIO, Wilkins MR. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aortocaval fistula rat. Cardiovasc Res. 29:1995;768-774.
7. Brown LA, Rutherford RAD, Nunez DJR, Wharton J, Lowe DG, Wilkins MR. Downregulation of natriuretic peptide C-receptor in the hypertrophied ventricle of the aortovenocaval fistula rat. Cardiovasc Res. 36:1997;363-371.
8. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature. 341:1989;68-72.
9. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
10. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ, Scarborough RM, Lewicki JA. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 78:1986;1362-1374.
11. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192.
12. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB. Atrial natriuretic peptides clearance receptor: complete sequence and functional expression cDNA clones. J Biol Chem. 263:1988;9395-9401.
13. Garcia R, Diebold S. Simple, rapid and effective method of producing aortocaval shunts in the rats. Cardiovasc Res. 24:1990;430-432.
14. Harada M, Saito Y, Kuwahara K, Ogawa E, Ishikawa M, Nakagawa O, Miyamoto Y, Kamitani S, Hamanaka I, Kajiyama N, Takahashi N, Masuda I, Itoh H, Nakao K. Interaction of myocytes and non-myocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol. 31:1998;S357-S359.
15. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, Suga S, Ogawa Y, Yasue H, Imura H. Expression of brain natriuretic peptide gene in human heart, production in the ventricle. Hypertension. 17:1991;1152-1155.
16. Kaiser M, Kahr O, Shimada Y, Smith P, Kelly M, Mahadeva H, Adams M, Lodwick D, Aalkjaer C, Avkiran M, Samani NJ. Differential regulation of ventricular adrenomedullin and atrial natriuretic peptide gene expression in pressure and volume overload in the rat. Clin Sci. 94:1998;359-365.
17. Kawakami H, Okayama H, Hamada M, Hiwada K. Alteration of atrial natriuretic peptide and brain natriuretic peptide gene expression associated with progress and regression of cardiac hypertrophy in renovascular hypertensive rats. Clin Sci. 90:1996;197-204.
18. Kinnunen P, Vuolteenahon O, Uusimaa P, Ruskoaho H. Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium. Circ Res. 70:1992;1244-1253.
19. Kleinert HD, Volpe M, Odell G, Marion D, Atlas SA, Camargo MJ, Laragh JH, Maack T. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. Hypertension. 8:1986;312-316.
20. Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun. 159:1989;1420-1426.
21. Kojima M, Minamino M, Kangawa K, Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett. 276:1990;209-213.
22. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 86:1992;1081-1088.
23. Li H, Oparil S, Meng QC, Elton TS, Chen Y-F. Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia. Am J Physiol (Lung Cell Mol Physiol 12). 268:1995;L328-L335.
24. Lin X, Hanze J, Heese F, Sodmann R, Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res. 77:1995;750-758.
25. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 54:1992;11-27.
26. Maack T, Suzuki M, Almeida FA, NussenZveig D, Scarborough RM, McEnroe GA, Lewicki JA. Physiological role of silent receptors of atrial natriuretic factor. Science. 238:1987;675-678.
27. Melo LG, Veress AT, Ackermann U, Pang SC, Flynn TG, Sonnenberg H. Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. Regul Pept. 79:1999;109-115.
28. Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol. 27:1996;720-727.
29. Nunez DJ, Dickson MC, Brown MJ. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest. 90:1992;1966-1971.
30. Ogawa Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Hosoda K, Saito Y, Arai H, Suga S, Jougasaki M, Yamada T, Kambayashi Y, Inouye K, Imura H. Rat brain natriuretic peptide-tissue distribution and molecular form. Endocrinology. 126:1990;2225-2227.
31. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest. 93:1994;1911-1921.
32. Perrella MA, Aarhus LL, Heublein DM, Lewicki JA, Burnett JC Jr. Biological role of atrial natriuretic factor clearance receptor in congestive heart failure. Am J Physiol. 265:1993;H401-H408.
33. Porter JG, Arfsten A, Fuller F, Miller JA, Gregory LC, Lewicki JA. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun. 171:1990;796-803.
34. Rockman HA, Wachhorst SP, Mao L, Ross J Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol. 266:1994;H2468-H2475.
35. Rutherford RA, Wharton J, Gordon L, Moscoso G, Yacoub M, Polak JM. Endocardial localization and characterization of natriuretic peptide binding sites in human fetal and adult heart. Eur J Pharmacol. 212:1992;1-7.
36. Ruzicka M, Skarda V, Leenen FHH. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation. 92:1995;3568-3573.
37. Schiffrin EL. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci. 74:1988;213-218.
38. Schultz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 58:1989;1155-1162.
39. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homcy C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by complementary DNA clone. Science. 225:1984;324-326.
40. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusiongenes. Hypertension. 16:1990;301-307.
41. Stingo AJ, Clavell AL, Heublein DM, Wei C-M, Pitteldow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 263:1992;H1318-H1321.
42. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-81.
43. Suga S, Nakao K, Itoh H, Komats Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta: possible existence of "vascular natriuretic peptide system" J Clin Invest. 90:1992;1145-1149.